KATHLEEN STIDHAM: Open Payments
NPI 1487814331 · PASCO, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 66 payments from 13 companies in 2025. Trend: 2023 $1,400 · 2024 $1,275 · 2025 $1,192
Food & beverage: $1,123Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $261 |
| Janssen Biotech, Inc. | 8 | $177 |
| Regeneron Healthcare Solutions, Inc. | 8 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| UCB, Inc. | 5 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $101 |
| Lilly USA, LLC | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 4 | $59 |
| GENZYME CORPORATION | 2 | $57 |
| Organon LLC | 4 | $44 |
Products named: RINVOQ, TREMFYA, DUPIXENT, Bimzelx, SPEVIGO, LIBTAYO, TALTZ, Sotyktu.
Industry payments across WA — which companies pay providers there.
